anti-CD47 antibody (Stanford University)

N/A

Report date: 2025/03/14 16:44:53

Base Information

Drug Nameanti-CD47 antibody (Stanford University)
Drug Alias NameCD47 checkpoint inhibitor (Stanford University)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionCluster of differentiation 47 inhibitors
TargetsCluster of differentiation 47
Therapy Area/IndicationsBrain NeoplasmsOligodendroglioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesStanford University
China Registration ClassN/A

Develop Information

Active CompaniesStanford University
Inactive CompaniesN/A
Active IndicationsBrain NeoplasmsOligodendroglioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A